Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New GSK lung drug hits most targets in two studies
New GSK lung drug hits most targets in two studies
New GSK lung drug hits most targets in two studies
Submitted by
admin
on June 3, 2011 - 9:18am
Source:
Yahoo/Reuters
News Tags:
GSK
Relovair
Theravance
COPD
Headline:
New GSK lung drug hits most targets in two studies
Do Not Allow Advertisers to Use My Personal information
